Gwynfor Owen Humphreys
Geen lopende functies
Loopbaan van Gwynfor Owen Humphreys
Eerdere bekende functies van Gwynfor Owen Humphreys
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AVACTA GROUP PLC | Directeur/Bestuurslid | 13-07-2006 | 23-01-2015 |
| Voorzitter | 24-12-2010 | 24-01-2014 | |
| GUNSYND PLC | Directeur/Bestuurslid | 01-10-2004 | 15-09-2014 |
| Algemeen Directeur | 03-05-2012 | 15-09-2014 | |
Nektar Therapeutics UK Ltd.
 Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Oprichter | 01-12-1995 | 01-01-2001 |
| President | 01-12-1995 | 01-01-2001 | |
SolAeroMed, Inc.
 SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Directeur/Bestuurslid | - | - |
Statistieken
Internationaal
| Verenigd Koninkrijk | 4 |
| Canada | 2 |
Operationeel
| Director/Board Member | 3 |
| Chairman | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| GUNSYND PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
SolAeroMed, Inc.
SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Health Technology |
